Thomas Jefferson University

Michael Kelly

TitleAsst Prof CHP
InstitutionThomas Jefferson University
DepartmentJSP - Pharmacy Practice
Address130 S. 9th Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kelly MS, Scopelliti EM, Goodson KE, Lo CMA, Nguyen HX, Simon B. Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2024 Sep 09. PMID: 39248221.
      Citations:    
    2. Kelly MS, Dacey A, Siana A, Ojeda J. Efficacy and Safety of a polypill to reduce cardiovascular events: A review of clinical trials. J Cardiovasc Pharmacol. 2023 Nov 04. PMID: 37924288.
      Citations:    
    3. Kelly MS, Sulaica EM, Beavers CJ. Role of Bempedoic Acid in Dyslipidemia Management. J Cardiovasc Pharmacol. 2020 10; 76(4):376-388. PMID: 32732494.
      Citations:    
    4. Board C, Kelly MS, Shapiro MD, Dixon DL. PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy. J Cardiovasc Pharmacol. 2020 05; 75(5):410-420. PMID: 32379108.
      Citations:    
    5. Kelly MS, Lewis J, Huntsberry AM, Dea L, Portillo I. Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease. Postgrad Med. 2019 Jan; 131(1):31-42. PMID: 30449220.
      Citations:    
    6. Sisson EM, Pamulapati L, Bucheit JD, Kelly MS, Dixon DL. Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future. Pharmacotherapy. 2018 02; 38(2):164-171. PMID: 29266309.
      Citations:    
    7. Baker WL, Buckley LF, Kelly MS, Bucheit JD, Parod ED, Brown R, Carbone S, Abbate A, Dixon DL. Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017 May 18; 6(5). PMID: 28522675.
      Citations:    
    Kelly's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (46)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _